Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR.
Tao WH, Shan XS, Zhang JX, Liu HY, Wang BY, Wei X, Zhang M, Peng K, Ding J, Xu SX, Li LG, Hu JK, Meng XW, Ji FH.
Tao WH, et al. Among authors: zhang m, zhang jx.
Front Pharmacol. 2022 Jun 14;13:782466. doi: 10.3389/fphar.2022.782466. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35873574
Free PMC article.